Commentary: Treating severe and complicated malaria

British Medical Journal

Volumn 328, Issue 7432, 2004, Pages 155-

  D'Alessandro, Umberto ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; HLA ANTIGEN; QUININE; ANTIMALARIAL AGENT;

AGE DISTRIBUTION; ANTIMALARIAL ACTIVITY; CHILDHOOD MORTALITY; CLINICAL FEATURE; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG INFUSION; DRUG TOLERABILITY; EVALUATION; HUMAN; HYPOGLYCEMIA; IMMUNE RESPONSE; INFECTION COMPLICATION; INFECTION RISK; INJECTION SITE; MALARIA FALCIPARUM; METABOLIC ACIDOSIS; NOTE; PARASITE TRANSMISSION; PRIORITY JOURNAL; RISK FACTOR; BLOOD TRANSFUSION; CRITICAL ILLNESS; METHODOLOGY;

ANTIMALARIALS; BLOOD TRANSFUSION; CRITICAL ILLNESS; HUMANS; MALARIA, FALCIPARUM;

EID: 1642504235     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (6)

1. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000;94(suppl 1):1-74.
2. World Health Organization. The use of antimalarial drugs:report of a WHO informal consultation. Geneva: WHO, 2001.
3. Winstanley P. Modern chemotherapeutic options for malaria. Lancet Infectious Diseases 2001;1:242-50.
4. Barennes H, Kailou D, Pussard E, Munjakazi JM, Fernan M, Sherouat H, et al. Administration intrarectale de la quinine: un traitement précoce du paludisme grave de l'enfant? Cahiers d'études et de recherche francophones/Santé 2001;11:145-53.
5. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995;332:1399-404.
6. D'Alessandro U, Olaleye B, Langerock P, Bennett S, Cham K, Cham B, et al. The Gambian national impregnated bednet programme: evaluation of effectiveness by means of case-control studies. Trans R Soc Hyg Trop Med 1997;91:638-42.